Quantitation of Glymphatic Functioning in Sleep and Meditative States Trial N/A Completed Aug. 5, 2025
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy Trial Phase 2 Terminated Aug. 5, 2025
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy Trial Phase 2 Terminated Aug. 5, 2025
CUE1+ device improves motor and non-motor outcomes in Parkinson’s disease: Findings from a QMUL double-blind, sham-controlled, randomised study News Charco Neurotech Aug. 5, 2025
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease Trial N/A Recruiting Aug. 4, 2025
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy Trial Phase 2 Active, not recruiting Aug. 4, 2025
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases Trial N/A Enrolling by invitation Aug. 4, 2025
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases Trial N/A Recruiting Aug. 2, 2025
Evaluation of GM101 Injection in Patients With Parkinson's Disease Trial Early Phase 1 Recruiting Aug. 2, 2025
EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease Trial N/A Completed July 31, 2025
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease Trial Phase 1 Recruiting July 31, 2025
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Trial N/A Suspended July 30, 2025
Parkinson's Research In Metagenomic Early Stage Biomarkers Trial N/A Not yet recruiting July 30, 2025
Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease Trial N/A Not yet recruiting July 30, 2025
Integration of Augmented Visual Feedback in Action Observation and Motor Imagery Therapy for Parkinson's Disease Trial N/A Not yet recruiting July 29, 2025
Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study Trial Phase 2 Completed July 29, 2025